FDA Reports Maxipime is Safe for Now
On June 17, 2009, the FDA reported the conclusions of its studies on Maxipime, an antibiotic generically known as cefepime. Maxipime is a Bristol Meyers Squibb drug used to treat infections caused by abdominal surgery and other conditions. A recent published study suggested that patients given the drug might be more likely to suffer deadly complications compared to patients treated with other drugs. The FDA determined that Maxipime did not increase the rate of death in its users. The FDA reviewed the study’s data and conducted additional analyses based on additional data, including data provided by Bristol Meyers Squibb.
In a letter it sent to healthcare professionals, the FDA stated that it still approved Maxipime as an appropriate treatment for its approved indications, at least for now. However, the FDA will continue to investigate into the safety of Maxipime. As part of its ongoing investigation, both the FDA and Bristol Meyers Squibb are conducting separate studies on Maxipime’s potential link to increased death rates in its users. The results of these studies will be reported in approximately a year.
Currently, the FDA has not indicated that Maxipime is a dangerous drug, but perhaps as it continues to do further investigations into the drug, it will find contrary information. If you or loved one has been harmed by a dangerous drug, contact a dangerous drug lawyer today.
Tags: Bristol Meyers Squibb, cefepime, dangerous drug, FDA, lawsuit, lawyer, maxipime